All treatments
Treatment
Alecensa 150 mg hard capsules clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
A phase II trial of an individualized treatment strategy for patients with metastatic non-clear cell renal carcinoma
This study is testing different medicines for people with advanced kidney cancer (non-clear cell renal carcinoma) that has spread. It's looking for personalised treatments to see which ones shrink the cancer and how long they keep it under control. The goal is to find better ways to treat this type of cancer.
For: Metastatic non-clear cell renal cell carcinomaDenmark - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Randomized, Multicenter, Phase III, Open-Label Study of Alectinib Versus Crizotinib In Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer
This study compared two cancer drugs, Alecensa and XALKORI, for people with a specific type of advanced lung cancer (ALK-positive non-small cell lung cancer) who haven't had treatment before. Researchers wanted to see which drug worked better at stopping cancer growth and how patients felt.
For: Anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC)Poland · Spain · Portugal